Latest news with #DraftRedHerringProspectus
Economic Times
4 hours ago
- Business
- Economic Times
Indira IVF IPO: EQT-backed fertility clinic chain refiles draft papers with Sebi via confidential route
Fertility chain Indira IVF has refiled its Draft Red Herring Prospectus (DRHP) through the confidential filing route, reviving its public listing plans, according to sources. Tired of too many ads? Remove Ads Tired of too many ads? Remove Ads Fertility chain Indira IVF has refiled its Draft Red Herring Prospectus (DRHP) through the confidential filing route, reviving its public listing plans, according to move comes amidst growing investor interest in the Indian assisted reproductive technology (ART) sector, buoyed by increasing awareness, expanding market size, and favorable people familiar with the matter, Bloomberg on Tuesday had reported that Indira IVF Hospital will soon submit preliminary documents for a listing that may fetch Rs 3,500 crore ($408 million).The company is backed by private equity firm EQT AB. The deal won't involve the issue of new stock as existing shareholders will be selling their holdings, the report said, quoting the will probably offload 29 billion rupees of shares in the offering, and three members of the founding family — Ajay Murdia, Kshitiz Murdia and Nitiz Murdia — will each sell shares worth 2 billion rupees, the people company had initially submitted a draft prospectus in February but withdrew it in March. The withdrawal came as the IPO plans coincided with the release of a Bollywood biopic based on the company's founder, which drew concerns from the Securities and Exchange Board of developments signal renewed IPO momentum in India's fertility and women's health segment, with investors closely watching how these companies position themselves in a competitive and rapidly evolving healthcare Mahindra Capital Co., IIFL Capital Services Ltd. , JPMorgan Chase & Co. and UBS Group AG are advising on the as per sources, Gaudium IVF and Women Health, another prominent player in the fertility care space, is also preparing to refile its DRHP in the immediate future, as part of its continued efforts to tap into capital markets and fuel its next phase of growth.
Time of India
4 hours ago
- Business
- Time of India
Indira IVF IPO: EQT-backed fertility clinic chain refiles draft papers with Sebi via confidential route
Fertility chain Indira IVF has refiled its Draft Red Herring Prospectus (DRHP) through the confidential filing route, reviving its public listing plans, according to sources. The move comes amidst growing investor interest in the Indian assisted reproductive technology (ART) sector, buoyed by increasing awareness, expanding market size, and favorable demographics. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like SRM Online MBA | India's top ranked institute SRM Online Learn More Undo Citing people familiar with the matter, Bloomberg on Tuesday had reported that Indira IVF Hospital will soon submit preliminary documents for a listing that may fetch Rs 3,500 crore ($408 million). The company is backed by private equity firm EQT AB. The deal won't involve the issue of new stock as existing shareholders will be selling their holdings, the report said, quoting the sources. EQT will probably offload 29 billion rupees of shares in the offering, and three members of the founding family — Ajay Murdia, Kshitiz Murdia and Nitiz Murdia — will each sell shares worth 2 billion rupees, the people said. Live Events The company had initially submitted a draft prospectus in February but withdrew it in March. The withdrawal came as the IPO plans coincided with the release of a Bollywood biopic based on the company's founder, which drew concerns from the Securities and Exchange Board of India. Both developments signal renewed IPO momentum in India's fertility and women's health segment, with investors closely watching how these companies position themselves in a competitive and rapidly evolving healthcare vertical. Kotak Mahindra Capital Co., IIFL Capital Services Ltd. , JPMorgan Chase & Co. and UBS Group AG are advising on the IPO. Meanwhile, as per sources, Gaudium IVF and Women Health, another prominent player in the fertility care space, is also preparing to refile its DRHP in the immediate future, as part of its continued efforts to tap into capital markets and fuel its next phase of growth.
Hindustan Times
a day ago
- Business
- Hindustan Times
WeWork India gets SEBI nod to launch IPO, promoters to sell shares to monetise investments
New Delhi, Jul 15 (PTI) Co-working major WeWork India has received market regulator Sebi's go-ahead to launch its Initial Public Offering (IPO), enabling the promoters to monetise their investments amid record demand for office spaces across the top seven cities. Co-working major WeWork India has received market regulator Sebi's go-ahead to launch its Initial Public Offering (IPO), enabling the promoters to monetise their investments amid record demand for office spaces across the top seven cities. (Picture for representational purposes only)(Pixabay) Bengaluru-based WeWork India Management Ltd, which filed its Draft Red Herring Prospectus (DRHP) in February, obtained observations from the markets regulator on July 8, an update with the SEBI showed on Tuesday. Established in 2017, WeWork India is promoted by Bengaluru-based real estate company Embassy Group. It has the exclusive license of the 'WeWork' brand in India. Also Read: Incuspaze acquires Pune's Trios to expand coworking biz, targets ₹350-400 crore During the 2023-24 fiscal, WeWork India posted a net loss of ₹135.83 crore over a total income of ₹1,737.16 crore. The company, however, posted a profit of ₹174.13 crore in the first six months of the 2024-25 fiscal. Total income stood at ₹960.76 crore during the April-September period of the 2024-25 financial year. In WeWork India, Embassy Group has around 76.21 per cent stake while WeWork Global owns 23.45 per cent. As per the DRHP, the proposed IPO is entirely an Offer for Sale (OFS) of up to 4.37 crore equity shares. Promoter group firm Embassy Buildcon LLP and investor 1 Ariel Way Tenant Ltd (part of WeWork Global) will offload shares. Through the OFS, Embassy Buildcon LLP will sell up to 33,458,659 equity shares, while 1 Ariel Way Tenant Ltd up to 10,295,293 shares. Since it is an OFS, WeWork India will not receive any proceeds from the IPO. On Monday, Smartworks Coworking Spaces Ltd's ₹583 crore IPO was subscribed 13.45 times. Awfis and EFC (I) Ltd are already listed on the stock exchanges. Co-working operators are tapping capital markets to raise funds for expansion amid rising demand for both conventional and flexible managed workspaces. In its draft papers, WeWork India stated that the object of the offer is to achieve the benefits of listing the equity shares on the stock exchanges. "Our company expects that listing of the equity shares will enhance our visibility and brand and provide liquidity to its existing shareholders. The listing will also provide a public market for the equity shares in India," WeWork India had said in the DRHP. Also Read: Mumbai real estate: WeWork India leases 1.26 lakh sq ft of commercial space in Powai for ₹1.38 crore monthly rent WeWork Global had in June 2021 invested USD 100 million in WeWork India. In January this year, the company raised ₹500 crore through a rights issue, mainly to reduce debt and achieve further growth. WeWork India provides flexible, high-quality workspaces to customers, which include companies of all sizes as well as individuals. It primarily leases Grade A office space from leading developers across Tier 1 cities and designs, builds, and operates them as flexible workspaces. Its portfolio comprises 77 lakh square feet of area, of which 70 lakh square feet is already operational. The operational desk capacity has reached 1.03 lakh. The company has a presence in Bengaluru, Mumbai, Pune, Hyderabad, Gurugram, Noida, Delhi, and Chennai. It has more than 500 employees.
&w=3840&q=100)
Business Standard
a day ago
- Business
- Business Standard
HDFC AMC up 3%, Nippon hits new high; time to buy, hold or sell AMC shares?
HDFC Asset Management Company, Nippon share price today Shares of HDFC Asset Management Company (AMC) and Nippon Life India Asset Management (NAM-India) moved higher by 3 per cent on the BSE in Tuesday's intra-day trade on expectations of strong earnings. The stock price of NAM-India hit a record high of ₹835.80 in intra-day trade; while HDFC AMC hit an intra-day high of ₹5,260.25, and quoted close to its record high of ₹5,275 touched on June 9, 2025. In the past six months, HDFC AMC and NAM-India have outperformed the market by surging 30 per cent and 26 per cent, respectively, as compared to 7.6 per cent rise in the BSE Sensex. HDFC AMC, Nippon - Q1 results dates HDFC Asset Management Company has informed BSE that the meeting of the board of directors of the company is scheduled on Thursday, July 17, 2025, inter alia, to consider and approve unaudited standalone and consolidated financial results of the company for the quarter ending June 30, 2025 (Q1FY26). NAM-India said the meeting of the board of directors of the company is scheduled on July 28, 2025 to consider and approve the unaudited financial results for Q1FY26. Brokerages view on AMCs Kotak Institutional Equities expects HDFC AMC and Nippon to continue to deliver higher asset under management (AUM) growth over the next few quarters on the back of stronger net inflows - equity AUM for both may grow at 0.5-1 per cent per month on current flow run-rate. AMC stocks have seen a strong rally since February lows and are now -10 per cent to +10 per cent off previous peaks. Current multiples are stiffer compared to entry valuations at the time of our upgrade in February. The valuation premium to broader markets is also now back to the previous peak in June 2024. HDFC/Nippon's relatively stable net flows in the categories the brokerage firm said they track, even during the market correction, give comfort on AUM growth visibility and hence are supportive of valuations. Analysts at InCred Equities expect the inflow momentum to pick up pace in the near term and sustain the healthy momentum in the medium term led by higher participation from the retail segment, higher understanding of market volatility and rising investment discipline along with incrementally higher inflow from B-30 cities. The brokerage firm said it remains optimistic over the mid- to long-term horizon amid improving geographic penetration as well as the rising popularity of mutual fund schemes, mainly among the young and mid-income investors. 'We continue to maintain ADD rating on all listed AMC players and maintain NAM India as our top pick among AMCs for its consistent performance-led market share gains. We like HDFC AMC for market share gains and Aditya Birla Sun Life AMC for its turnaround story. The undercurrent of likely acquisition of UTI AMC makes its stock attractive,' analysts said AMCs report. ICICI Prudential AMC files DRHP ICICI Prudential Asset Management Company has filed its Draft Red Herring Prospectus (DRHP) with capital markets regulator, Securities and Exchange Board of India (SEBI) to raise funds through Initial Public Offering (IPO). ICICI Prudential AMC is a joint venture between ICICI Bank and Prudential Corporation Holdings Limited, operating since 1998. It is the largest asset management company in India in terms of active mutual fund quarterly average assets under management (QAAUM) with a market share of 13.3 per cent as of March 31, 2025 (Source: CRISIL Report).
&w=3840&q=100)
Business Standard
a day ago
- Business
- Business Standard
Upcoming IPO! STUDDS receives green signal from Sebi to go public; details
Upcoming IPO: Leading two-wheeler helmet manufacturer STUDDS Accessories is all set to go public, having received the green light from the market regulator, the Securities and Exchange Board of India (Sebi), for its long-awaited Initial Public Offering (IPO). The company initially submitted its draft papers to the markets regulator in 2018. However, the proposal was not executed at that time. Now, STUDDS has received Sebi's approval for its Draft Red Herring Prospectus (DRHP), which was submitted in March this year. STUDDS Accessories IPO details The public offering comprises an entirely Offer for Sale (OFS) of up to 7.78 million equity shares. From the promoters group, Madhu Bhushan Khurana, Sidhartha Bhushan Khurana, and Chand Khurana are divesting up to 6.7 million equity shares, while other shareholders are divesting up to 1.08 million equity shares of the company through the public issue. The equity shares offered through the DRHP are proposed to be listed on the BSE and the National Stock Exchange of India (NSE). MUFG Intime India (formerly Link Intime India) is the registrar of the offer, while IIFL Capital Services and ICICI Securities are the book running lead managers. The price band and the minimum bid lot, the company said, will be decided in accordance with applicable laws and in consultation with the book running lead managers. STUDDS Accessories will not receive any proceeds of the Offer for Sale by the selling shareholders. "Each of the selling shareholders will be entitled to the respective proportion of the proceeds of the OFS after deducting their portion of the offer-related expenses and the relevant taxes thereon," reads the DRHP. About STUDDS Accessories STUDDS Accessories designs, manufactures, markets, and sells two-wheeler helmets under the 'Studds' and 'SMK' brands and other accessories (such as two-wheeler luggage, gloves, helmet locking devices, rain suits, riding jackets, and eyewear) under the 'Studds' brand. The company is the largest two-wheeler helmet player in India in terms of revenue in Fiscal 2023 and also the world's largest two-wheeler helmet player by volume in Calendar Year 2024. (Source: CARE Report). The company's products are sold pan-India and in more than 70 countries internationally, with key export markets situated across the Americas, Asia (excluding India), Europe, and the rest of the world. For the six-month period ended September 30, 2024, the company reported revenue from operations of ₹285.31 crore and a net profit of ₹33.24 crore. In the fiscal year 2023–24 (FY24), STUDDS Accessories reported revenue from operations of ₹1,665.1 crore and a net profit of ₹57.22 crore.
